WeVote
Log In

Bill

Bill

SB 1822

Medical marijuana licenses; authorizing certain research license; requiring promulgation of certain rules. Effective date.

2026 Regular Session Introduced by Shane Jett

Oklahoma bill authorizes medical marijuana research licenses and directs agencies to create governing rules for licensed cannabis research operations.

Second Reading referred to Business and Insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 1822

Legislative bill overview

SB 1822 authorizes Oklahoma to issue research licenses for medical marijuana and requires state agencies to develop rules governing these research operations. The bill establishes a new licensing category within the existing medical marijuana framework to facilitate scientific studies on cannabis.

Why is this important

Research licenses could expand clinical knowledge about cannabis's medical applications, safety profiles, and efficacy for various conditions. This addresses a gap in the current Oklahoma medical marijuana system, which focuses on commercial cultivation and patient access but lacks formal research pathways aligned with potential federal cannabis reclassification.

Potential points of contention

  • Scope ambiguity: The bill doesn't specify which research activities qualify, what institutions can apply, or whether research must align with federal DEA scheduling—potentially creating regulatory uncertainty
  • Public health data access: Unclear whether research findings would be publicly available or belong to private entities, affecting transparency and scientific reproducibility
  • Implementation timeline: The bill mandates rule promulgation but sets no deadline, potentially delaying actual research license issuance by months or years while regulatory agencies develop frameworks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.